Preview: Mind Medicine's Earnings
Portfolio Pulse from Benzinga Insights
Mind Medicine (NASDAQ:MNMD) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.67. The company's past performance shows a trend of missing EPS estimates, which has often led to a drop in share price. The stock was trading at $2.56 as of October 31, with a 52-week return of -14.59%.
November 01, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Mind Medicine's upcoming earnings report could impact its stock price. The company has a history of missing EPS estimates, which has often resulted in a drop in share price.
Mind Medicine's stock price has historically been affected by its earnings reports, particularly when it misses EPS estimates. Given that analysts are predicting an EPS of $-0.67 for the upcoming report, and considering the company's past performance, there is a high likelihood that the stock price could be negatively impacted if the company fails to meet or exceed this estimate.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100